We are evaluating diagnostics that are fit for the needs of older patients. This builds on the North East’s international reputation for research excellence in ageing.
We are expanding our proficiency in evaluating diagnostic tests for infectious diseases. We are particularly focused on improved detection of sepsis and, more recently, COVID-19.
We are evaluating tests that identify patients who will respond to specific treatments. This will strengthen the North East's world leading expertise in cancer and inherited diseases.
We have expertise in methods that can support developers and improve the design of their diagnostics and future studies.
We offer statistical expertise. We can help with the set-up and analysis of studies that evaluate the accuracy and utility of new tests.
We have expertise in health economics. We can help developers explore the impact of their new diagnostics on the healthcare system.